Literature DB >> 12566376

Myocardial infarct expansion and matrix metalloproteinase inhibition.

Rupak Mukherjee1, Theresa A Brinsa, Kathryn B Dowdy, Amelia A Scott, Julia M Baskin, Anne M Deschamps, Abigail S Lowry, G Patricia Escobar, David G Lucas, William M Yarbrough, Michael R Zile, Francis G Spinale.   

Abstract

BACKGROUND: A potential mechanism for left ventricular (LV) remodeling after myocardial infarction (MI) is activation of the matrix metalloproteinases (MMPs). This study examined the effects of MMP inhibition (MMPi) on regional LV geometry and MMP levels after MI. METHODS AND
RESULTS: In pigs instrumented with radiopaque markers to measure regional myocardial geometry, MI was created by ligating the obtuse marginals of the circumflex artery. In the first study, pigs were randomized to MMPi (n=7; PD166793, 20 mg x kg(-1) x d(-1)) or MI only (n=7) at 5 days after MI, and measurements were performed at 2 weeks. Regional MI areas were equivalent at randomization and were increased in the MI-only group at 2 weeks after MI compared with the MMPi group. In the second study, pigs randomized to MMPi (n=9) or MI only (n=8) were serially followed up for 8 weeks. At 8 weeks after MI, LV end-diastolic dimension was lower with MMPi than in the MI-only group (4.7+/-0.1 versus 5.1+/-0.1 cm, P<0.05). Regional MI area was reduced with MMPi at 8 weeks after MI (1.3+/-0.1 versus 1.7+/-0.1 cm2, P<0.05). MMPi reduced ex vivo MMP proteolytic activity. In the MI region, membrane-type MMP levels were normalized and levels of the endogenous tissue inhibitor of MMPs (TIMP-1) were increased compared with normal levels with MMPi. These effects were not observed in the MI-only group.
CONCLUSIONS: MMPi attenuated the degree of post-MI LV dilation and expansion of the infarct during the late phase of MI healing. In addition, exogenous MMPi caused region-specific modulation of certain MMP and TIMP species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566376     DOI: 10.1161/01.cir.0000046449.36178.00

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  85 in total

1.  Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury.

Authors:  Rupak Mukherjee; Gregory P Colbath; Charles D Justus; James A Bruce; Claire M Allen; Kenneth W Hewett; J Philip Saul; Robert G Gourdie; Francis G Spinale
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

2.  Helix-loop-helix protein p8, a transcriptional regulator required for cardiomyocyte hypertrophy and cardiac fibroblast matrix metalloprotease induction.

Authors:  Sandro Goruppi; Richard D Patten; Thomas Force; John M Kyriakis
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

3.  Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Jennifer R Allport; Si Chen; Ralph Weissleder; Paul L Huang
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

Review 4.  Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction.

Authors:  Keyur B Shah; Stephen S Gottlieb
Journal:  Curr Heart Fail Rep       Date:  2004-12

5.  Cyclosporin A in left ventricular remodeling after myocardial infarction.

Authors:  Andaleb Kholmukhamedov; Christina Logdon; Jiangting Hu; Richard A McKinney; Francis G Spinale; John J Lemasters; Rupak Mukherjee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

6.  Short-term disruption in regional left ventricular electrical conduction patterns increases interstitial matrix metalloproteinase activity.

Authors:  Rupak Mukherjee; Juozas A Zavadzkas; William T Rivers; Julie E McLean; Eileen I Chang; Shenikqua Bouges; Robert G Matthews; Christine N Koval; Robert E Stroud; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-14       Impact factor: 4.733

7.  Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.

Authors:  Shaina R Eckhouse; Brendan P Purcell; Jeremy R McGarvey; David Lobb; Christina B Logdon; Heather Doviak; Jason W O'Neill; James A Shuman; Craig P Novack; Kia N Zellars; Sara Pettaway; Roy A Black; Aarif Khakoo; Taeweon Lee; Rupak Mukherjee; Joseph H Gorman; Robert C Gorman; Jason A Burdick; Francis G Spinale
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

8.  Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.

Authors:  Takayuki Fujiwara; Toshiro Matsunaga; Kunihiko Kameda; Naoki Abe; Hirotsugu Ono; Takumi Higuma; Jin Yokoyama; Hiroyuki Hanada; Tomohiro Osanai; Ken Okumura
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

9.  Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.

Authors:  David C Lobb; Heather Doviak; Gregory L Brower; Eva Romito; Jason W O'Neill; Stephen Smith; James A Shuman; Parker D Freels; Kia N Zellars; Lisa A Freeburg; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2020-09-21       Impact factor: 4.030

10.  MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.

Authors:  Shauna M Dorsey; Jeremy R McGarvey; Hua Wang; Amir Nikou; Leron Arama; Kevin J Koomalsingh; Norihiro Kondo; Joseph H Gorman; James J Pilla; Robert C Gorman; Jonathan F Wenk; Jason A Burdick
Journal:  Biomaterials       Date:  2015-08-06       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.